Detection of Increased Expression of Claudin-1 in Triple-Negative Breast Cancer: Analysis and Clinical-Pathological Correlation

Background Triple-negative breast cancer (TNBC) is a highly aggressive disease that lacks therapeutic targets and prognostic biomarkers. Claudin-1 is a well-described tight junction protein with prognostic value in many human cancers. Aims The need for the discovery of biomarkers of TNBC disease was...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouban, Abderrahman, Ameer, Omar Z, Quek, Ko Jin, Arafah, Maria A, Raddaoui, Layla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123009/
https://www.ncbi.nlm.nih.gov/pubmed/37102018
http://dx.doi.org/10.7759/cureus.36648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123009/
https://www.ncbi.nlm.nih.gov/pubmed/37102018
http://dx.doi.org/10.7759/cureus.36648

Ejemplares similares